Mrs. Michelle Chalker1, Professor Brett Mitchell1,2,3,4,5, Dr Kate Browne1, Professor Philip Russo2,6,1
1Avondale University, Cooranbong, Australia, 2Monash University, Clayton, Australia, 3University of Newcastle, Callaghan, Australia, 4Hunter Medical Research Institute, New Lambton Heights, Australia, 5Central Coast Local Health District, Gosford, Australia, 6Calibri Health, Malvern, Australia
Biography:
Michelle Chalker is a nursing lecturer and PhD candidate at Avondale University working with Professor Brett Mitchell. Michelle is a RN with clinical and IPC experience before moving into nursing education. Michelle's research focuses on the impact of non-ventilator healthcare-associated pneumonia (NV-HAP) on length of stay and mortality in Australia.
Abstract:
Introduction
Healthcare-associated pneumonia has been identified as one of the most common healthcare-associated infections in point prevalence studies. Non-ventilator healthcare associated pneumonia (NV-HAP) is considered to have significant impact on a patients hospital length of stay and mortality. There is little high-quality research exploring the incidence, additional length of stay, requirement of ICU admission and mortality due to NV-HAP using appropriate statistical methods.
Methods
A retrospective cohort study of 60,000 persons hospitalised across two participating hospitals, who have been admitted for 48 hours or greater and are aged 18 years or older will be used in this study. Data collection will be undertaken by review of electronic medical records. All data collected pertaining to participants will be directly entered into REDCap®. Additionally, a matched nested case-control study embedded in the cohort study will be undertaken with matching factors of age, sex and period of hospital admission. Descriptive and statistical analysis will be used to report finding from the research results.
Results
This research will determine the incidence of NV-HAP, impact of NV-HAP on prolonging length of stay in hospital, admission to ICU due to NV-HAP diagnosis and inpatient mortality. Additionally, healthcare-associated pneumonia definitions used in hospital surveillance will also be compared.
Conclusion
These findings seek to gain knowledge insight and understanding of incidence and outcomes in patients diagnosed with NV-HAP in Australia.